You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B

Citation Tools

Article menu
XML
Oncolytic and local immunotherapy
Original research
Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Alvarez de Cienfuegos A, Cheung LH, Mohamedali KA, et al
Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B
Journal for ImmunoTherapy of Cancer 2020;8:e001138. doi: 10.1136/jitc-2020-001138